SEATTLE GENETICS ADC

Dec 19, 11
Other articles:
  • Jan 7, 2011 . Seattle Genetics has signed an agreement with Pfizer, under which Pfizer will
  • Senior Staff Writer Seattle Genetics Inc. found another interested suitor for its
  • Seattle Genetics' antibody-drug conjugate (ADC) technology empowers
  • May 2, 2011 . Seattle Genetics brentuximab vedotin was submitted for . accepted their BLA
  • Sep 14, 2011 . Seattle Genetics and Oxford BioTherapeutics (OBT) established a collaboration
  • Seattle Genetics Highlights ADC Technology Research at AACR. Last Update: 4/
  • Antibody-drug Conjugate Technology Collaborations. Seattle Genetics has
  • Jun 9, 2011 . Seattle Genetics and Agensys are also co-developing another ADC known . the
  • Oct 25, 2011 . Seattle Genetics has collaborations for its ADC technology with a number of
  • Dec 12, 2011 . Seattle Genetics has collaborations for its ADC technology with a number of
  • Oct 10, 2011 . Currently, only Seattle Genetics and ImmunoGen (IMGN) have succeeded in
  • Aug 22, 2011 . Adcetris is indicated for Hodgkin lymphoma and systemic anaplastic large cell
  • Oct 11, 2011 . Currently, only Seattle Genetics and ImmunoGen (IMGN) have succeeded in
  • 6 days ago . Seattle Genetics has collaborations for its ADC technology with a number of
  • Oct 10, 2011 . The antibodies generated by OBT will then be screened for activity using Seattle
  • Aug 19, 2011 . -First in a new class of ADCs to be FDA-approved-. -Seattle Genetics to
  • Aug 22, 2011 . Seattle Genetics expects to make Adcetris available to patients next week.
  • Apr 19, 2011 . Under the new agreement, Genmab has rights to utilize Seattle Genetics' ADC
  • Oct 25, 2011 . The World ADC Summit is the chosen platform for the leading companies
  • Feb 13, 2011 . The company announced that Genentech recently advanced 3 new antibody
  • Mar 22, 2011 . Seattle Genetics to receive $8 million upfront payment, plus potential milestone
  • The antibody causes the ADC to bind to the target cancer cells. . Seattle
  • Seattle Genetics Highlights ADC Technology Research at AACR Last Update: 4/
  • Additionally, Seattle Genetics licenses its ADC technology to larger drugmakers
  • 6 days ago . Seattle Genetics has collaborations for its ADC technology with a number of
  • GSK is responsible for research, product development, manufacturing and
  • Sep 27, 2010 . After years of plugging away at antibody-drug conjugates, Seattle Genetics has
  • 6 days ago . Seattle Genetics has collaborations for its ADC technology with a number of
  • Sep 14, 2011 . Seattle Genetics, Inc. and Oxford BioTherapeutics today announced that they
  • Drug Name: Adcretris (brentuximab vedotin). Company: Seattle Genetics
  • Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Daiichi
  • Jun 9, 2011 . Seattle Genetics and Agensys (now owned by Astellas) will work on their second
  • Aug 22, 2011 . Equally important, the approval is an endorsement of the ADC technology.
  • 6 days ago . Seattle Genetics has collaborations for its ADC technology with a number of
  • Mar 22, 2011 . Milestone fees due to Seattle Genetics could total $200 million.
  • Apr 19, 2011 . Genmab and Seattle Genetics have entered into their second antibody-drug
  • Seattle Genetics' ADC technology employs synthetic, highly potent drugs that are
  • Sep 13, 2011 . The antibodies generated by OBT will then be screened for activity using Seattle
  • Apr 5, 2011 . Apr 5, 2011 - Seattle Genetics, Inc. (Nasdaq SGEN) today announced that
  • Genmab A/S And Seattle Genetics Expand Antibody-Drug Conjugate . If Seattle
  • Aug 22, 2011 . A great technology, the antibody-drug conjugate (ADC) technology, which is
  • Mar 23, 2011 . In a third licensing deal this year, Seattle Genetics (Nasdaq: SGEN) says it has
  • Dec 7, 2011 . Seattle Genetics has collaborations for its ADC technology with a number of
  • Nov 9, 2011 . November 8, 2011 – Seattle Genetics, Inc. (NASDAQ: SGEN) and with its .
  • Seattle Genetics Achieves Milestone Under Millennium Collaboration for European Medicines Agency Acceptance of Brentuximab Vedotin MAA. 06/17/2011
  • Brentuximab vedotin is empowered by Seattle Genetics' proprietary antibody-
  • Dec 12, 2011 . Seattle Genetics has collaborations for its ADC technology with a number of
  • Dec 12, 2011 . Seattle Genetics has collaborations for its ADC technology with a number of
  • Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with
  • Mar 22, 2011 . Today, Seattle Genetics announced a partnership with Abbott to develop a drug
  • With partner Millennium Pharmaceuticals , the company is working to expand

    • Sitemap